|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Comparison of subcu- taneous interferon beta-la with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Ace- tate in Relapsing MS Disease I-REGARDlstudy) : a muhicen- tre, randomised, parallel, open-label trial显示文摘 | Mikol DD Barkhof F Chang P | 2008 | Lancet Neu- rol2008，7，10： | 1 |
| 2 | Comparison of sub- cataneous interferon beta- la with glatiramer acetate in patients with relapsing multiple sclerosis (the Rebif Vs- Glatirsmer Acetate in RelapsingMS Disease study) amulticentre, randomised, parllel, open label trial 显示文摘 | Mikol DD Brakho{ F Chang P | 2008 | Lancet Neurol2008，7，10： | 1 |
| 3 | Comparison of subcataneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis(the REbif vs Glatirsmer Acetate in Relapsing MS Diseasestudy):a multicentre,randomised,parallel,open-label trial显示文摘 | Mikol DD Barkhof F Chang P | 2008 | Lancet Neurol2008，7，10： | 1 |
| 4 | Oculomotor lesions and myeloma: a case with a CT scan study ( author' s transl ) 显示文摘 | Mikol F Aubin ML Dubus H | 1981 | Rev Neurol (Paris)1981，137，2： | 1 |
| 5 | Comparison of subcutaneous interferon beta - 1 a with glatiramer acetate in pa- tients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease 显示文摘 | MIKOL D D BARKHOF F CHANG P | 2008 | Lancet Neurol2008，7，10： | 1 |
| 6 | The REGARD trial:a randomized assessor-blinded trial comparing interferon beta 1a and glatiramer acetate in relapsing-remitting multiple sclerosis显示文摘 | Mikol DD Barkhof F Chang PK | 2007 | Mult Scler2007，13，： | 1 |
| 7 | Isolated cranial nerve palsies may point to primary histiocytic sarcoma显示文摘 | Moulignier A Mikol J Heran F | 2014 | BMJ Case Rep2014，8，： | 1 |
| 8 | Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease[REGARD]study):a multicentre,randomised,parallel,open-label trial显示文摘 | Mikol DD Barkhof F Chang P | | 0，，10： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员